Are you Dr. Panwalkar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 33 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
820 4th St N
Fargo, ND 58102Phone+1 701-234-6161Fax+1 701-234-3861
Summary
- Dr. Amit Panwalkar, MD is an oncologist in Fargo, North Dakota. He is currently licensed to practice medicine in North Dakota and Minnesota. He is affiliated with Sanford Medical Center Fargo, Fargo VA Medical Center, and Sanford Wheaton Medical Center.
Education & Training
B.J. Medical College - University of PuneClass of 1999, MD
Certifications & Licensure
ND State Medical License 2002 - 2026
MN State Medical License 2008 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma Start of enrollment: 2013 Sep 16
- A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 22
Publications & Presentations
PubMed
- 163 citations24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small ...Hossein Borghaei, Corey J. Langer, Shirish M. Gadgeel, Vassiliki A. Papadimitrakopoulou, Amita Patnaik
Journal of Thoracic Oncology. 2019-01-01 - 86 citationsLong-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC.Mark M. Awad, Shirish M. Gadgeel, Hossein Borghaei, Amita Patnaik, James Chih-Hsin Yang
Journal of Thoracic Oncology. 2021-01-01 - 1052 citationsCarboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-...Corey J. Langer, Shirish M. Gadgeel, Hossein Borghaei, Vassiliki A. Papadimitrakopoulou, Amita Patnaik
The Lancet. Oncology. 2016-11-01
